Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2025-520910-67-01Phase 4Authorised
Phase 4, randomised, double-blind trial of ropivacaine and lidocaine in acute pain (6 arms), sponsored by Oslo University Hospital. Primary endpoint: Area of pinprick hyperalgesia induced by electrical stimulation. Planned start May 2026; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2025-520910-67-01.